ArticleBlood cancer discovery2022

Anti-spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic Malignancies.

Lee M Greenberger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.